A new analysis of National Lung Screening Trial (NLST) data has found that as many as one-fifth of all lung cancer diagnoses may represent overdiagnosis — that is, detection of indolent or slow-growing lung cancers that may never have harmed the patient, according to a report in JAMA Internal Medicine.
Read more here.
